Nasim Tabrizi
Overview
Explore the profile of Nasim Tabrizi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ehsani Z, Salehifar E, Habibi E, Alizadeh-Navaei R, Moosazadeh M, Tabrizi N, et al.
Int J Hematol Oncol Stem Cell Res
. 2024 Jun;
18(2):165-173.
PMID: 38868804
Chemotherapy-induced peripheral neuropathy (CIPN) is a significant cancer treatment side effect that can influence both quality of life and treatment course. Melissa Officinalis (MO), due to its high content of...
2.
Tabrizi N, Sharifi-Razavi A
World J Virol
. 2022 Dec;
11(6):467-476.
PMID: 36483103
Most of the antiseizure medications (ASMs) are metabolized in liver and many of them particularly first-generation ASMs have the potential to increase liver enzymes or induce liver injury. Hence, treatment...
3.
Cheraghmakani H, Rezapour M, Asghari F, Alizadeh-Navaei R, Ghazaeian M, Tabrizi N
Epilepsy Behav
. 2022 Oct;
136:108938.
PMID: 36228485
Background: Levetiracetam is a broad-spectrum antiseizure medication with known behavioral side effects. The possible beneficial effect of pyridoxine on improvement of these psychiatric problems has been suggested in few previous...
4.
Amiri H, Sharifi Razavi A, Tabrizi N, Cheraghmakani H, Baghbanian S, Sedaghat-Chaijan M, et al.
J Stroke Cerebrovasc Dis
. 2022 Apr;
31(7):106512.
PMID: 35489184
Objective: The objective of this study was to evaluate how COVID-19 affects patients with acute ischemic or hemorrhagic stroke outcome. Materials And Methods: This retrospective study was performed on adult...
5.
Ershadi F, Mousavi Mirzaei S, Tabrizi N, Roshanravan B, Sahebnasagh A, Avan R
Epilepsy Behav
. 2022 Mar;
129:108618.
PMID: 35257991
Background: Epilepsy is one of the most common neurologic unit diseases that have different prevalence in different parts of the world. Antiepileptic drugs (AEDs) are associated with major fertility risks...
6.
Cheraghmakani H, Rezai M, Valadan R, Rahimzadeh G, Moradi M, Jahanfekr V, et al.
Epilepsy Res
. 2021 Aug;
176:106742.
PMID: 34419770
Purpose: To investigate the efficacy of short-term treatment with ciprofloxacin in alteration of gut microbiota pattern and reduction of seizure frequency in adult patients with drug-resistant epilepsy. Methods: In a...
7.
Habibabadi J, Moein H, Jourahmad Z, Ahmadian M, Basiratnia R, Zare M, et al.
Epilepsy Behav
. 2021 Aug;
122:108221.
PMID: 34352668
Background: Our aim was to report the postoperative seizure outcome and associated factors in patients with lesional epilepsy, in a low-income setting. Methods: This longitudinal prospective study included patients who...
8.
Habibabadi J, Zare M, Naghibi S, Tabrizi N, Naghibi S
Am J Clin Exp Immunol
. 2020 Jul;
9(3):47-52.
PMID: 32704434
Background: Epilepsy is a chronic neurologic condition and affects peoples at all ages. Seizure clusters are generally referred to seizures that occur at close intervals with complete recovery between attacks....
9.
Ranjbar M, Habibabadi J, Poorazarian F, Mohammadi B, Naghibi S, Tabrizi N
Acta Neurol Belg
. 2020 Jun;
121(5):1247-1250.
PMID: 32507941
Patients with refractory epilepsy can suffer from psychological and physical problems. Epilepsy can also be associated with menstruation abnormalities in women. In this paper, we aim to survey women with...
10.
Habibabadi J, Zare M, Naghibi S, Afzali M, Adibi I, Tabrizi N, et al.
Int J Prev Med
. 2020 Mar;
11:19.
PMID: 32175059
Background: Epilepsy is a chronic neurologic condition and affects people of all ages. Seizure clusters are generally referred to seizures that occur at close intervals with complete recovery between attacks....